Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair

Liver International

Volumn 34, Issue 7, 2014, Pages

  Garcia Irigoyen, Oihane ^a   Carotti, Simone ^b   Latasa, Maria U ^a   Uriarte, Iker ^a,c   Fernández Barrena, Maite G ^a,c   Elizalde, Maria ^a   Urtasun, Raquel ^a   Vespasiani Gentilucci, Umberto ^b   Morini, Sergio ^b   Banales, Jesús M ^c,d   Parks, William C ^e   Rodriguez, Jose A ^a   Orbe, Josune ^a   Prieto, Jesús ^a,c   Páramo, Jose A ^a   Berasain, Carmen ^a,c   Ávila, Matías A ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Fibrinogen; Liver injury; Liver regeneration; MMP10

Indexed keywords

FIBRINOGEN; STROMELYSIN 2; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; ANTAGONISTS AND INHIBITORS; BILE DUCT; ENZYMOLOGY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LIGATION; LIVER; LIVER DISEASE; LIVER RESECTION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; REGENERATION; SURGERY; WESTERN BLOTTING;

ANIMALS; BILE DUCTS; BLOTTING, WESTERN; FIBRINOGEN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATECTOMY; IMMUNOHISTOCHEMISTRY; LIGATION; LIVER; LIVER DISEASES; MATRIX METALLOPROTEINASE 10; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; REGENERATION; TOLL-LIKE RECEPTOR 4;

EID: 84904515682     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12337     Document Type: Article

References (69)

1. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836-47.
2. Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010; 176: 2-13.
3. Böhm F, Köhler UA, Speicher T, Werner S. Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2010; 2: 294-305.
4. Uriarte I, Fernandez-Barrena MG, Monte MJ, et al. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 2013; 62: 899-910.
5. Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodelling at the early stages of liver regeneration in the rat. Hepatology 1997; 26: 896-904.
6. Mohammed FF, Khokha R. Thinking outside the cell: proteases regulate hepatocyte division. Trends Cell Biol 2005; 15: 555-63.
7. Bezerra JA, Bugge TH, Melin-Aldana H, et al. Plasminogen deficiency leads to impaired remodelling after a toxic injury to the liver. Proc Natl Acad Sci USA 1999; 96: 15143-8.
8. Neubauer K, Knittel T, Armbrust T, Ramadori G. Accumulation and cellular localization of fibrinogen/fibrin during short-term and long-term rat liver injury. Gastroenterology 1995; 108: 1124-36.
9. Tsujimoto I, Moriya K, Sakai K, Dickneite G, Sakai T. Critical role of factor XIII in the initial stages of carbon tetrachloride-induced adult liver remodelling. Am J Pathol 2011; 179: 3011-9.
10. Roselli HT, Su M, Washington K, et al. Liver regeneration is transiently impaired in urokinase-deficient mice. Am J Physiol Gastrointest Liver Physiol 1998; 275: G1472-9.
11. Ng VL, Sabla G, Melin-Aldana H, et al. Plasminogen deficiency results in poor clearance of non-fibrin matrix and persistent activation of hepatic stellate cells after an acute injury. J Hepatol 2001; 35: 781-9.
12. Shanmukhappa K, Matte U, Degen JL, Bezerra JA. Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair. J Biol Chem 2009; 284: 12917-23.
13. Kim TH, Mars WM, Stolz DB, Michalopoulos GK. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 2000; 30: 75-82.
14. Knittel T, Mehde M, Grundmann A, et al. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol 2000; 113: 443-53.
15. Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007; 46: 955-75.
16. Uchinami H, Seki E, Brenner DA, D'Armiento J. Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis. Hepatology 2006; 44: 420-9.
17. Fallowfield JA, Mizuno M, Kendall TJ, et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine fibrosis. J Immunol 2007; 178: 5288-95.
18. Olle EW, Ren X, McClintock SD, et al. Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice. Hepatology 2006; 44: 540-9.
19. Yan C, Zhou L, Han YP. Contribution of hepatic stellate cell and matrix metalloproteinase 9 in acute liver failure. Liver Int 2008; 28: 959-71.
20. Krampert M, Bloch W, Sasaki T, et al. Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 2004; 15: 5242-54.
21. Koller FL, Dozier EA, Nam KT, et al. Lack of MMP10 exacerbates experimental colitis and promotes development of inflammation-associated colonic dysplasia. Lab Invest 2012; 92: 1749-59.
22. Rodriguez JA, Orbe J, Martinez de Lizarrondo s, et al. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front Biosci 2008; 13: 2916-21.
23. Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 1998; 253: 67-75.
24. Orbe J, Barrenetxe J, Rodriguez JA, et al. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism. Circulation 2011; 124: 2909-19.
25. Bezerra JA, Currier AR, Melin-Aldana H, et al. Plasminogen activators direct reorganization of the liver lobule alter acute injury. Am J Pathol 2001; 158: 921-9.
26. Kassim SY, Gharib SA, Mecham BH, et al. Individual matrix metalloproteinases control distinct transcriptional responses in airway epithelial cells infected with Pseudomonas aeruginosa. Infect Immun 2007; 75: 564050.
27. Berasain C, García-Trevijano ER, Castillo J, et al. Amphiregulin: an early trigger of liver regeneration. Gastroenterology 2005; 128: 424-32.
28. Mitchell C, Mahrouf-Yorgov M, Mayeuf A, et al. Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease. Lab Invest 2011; 91: 273-82.
29. Perugorría MJ, Latasa MU, Nicou A, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology 2008; 48: 1251-61.
30. Rudich N, Zamir G, Pappo O, et al. Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gut. Liver Int 2009; 29: 1273-84.
31. Fernández-Barrena MG, Monte MJ, Latasa MU, et al. Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. J Hepatol 2012; 56: 367-73.
32. Latasa MU, Gil-Puig C, Fernández-Barrena MG, et al. Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice. PLoS ONE 2010; 5: e15690.
33. Lasarte JJ, Casares N, Gorraiz M, et al. The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 2007; 178: 748-56.
34. Berasain C, García-Trevijano ER, Castillo J, et al. Novel role for amphiregulin in protection from liver injury. J Biol Chem 2005; 280: 19012-20.
35. Luyendyk JP, Cantor GH, Kirchofer D, et al. Tissue factor-dependent coagulation contributes to α-naphthylisothiocyanate-induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296: G840-9.
36. Rabilloud T, Adessi C, Giraudel A, Lunardi J. Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1997; 18: 307-16.
37. Berasain C, Hevia H, Fernández-Irigoyen J, et al. Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma. Biochim Biophys Acta 2004; 1690: 276-84.
38. Gujral JS, Farhood A, Bajt ML, Jaeschke H. Neutrophils aggravate acute liver injury during obstructive cholestasis. Hepatology 2003; 38: 355-63.
39. Canbay A, Guicciardi ME, Higuchi H, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112: 152-9.
40. Österreicher CH, Trauner M. Animal models of biliary tract injury. Curr Opin Gastroenterol 2012; 28: 239-43.
41. Wilkins-Port C, Ye Q, Mazurkiewicz JE, Higgins PJ. TGF-β1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodelling axis: role for PAI-1. Cancer Res 2009; 69: 4081-91.
42. Ishikawa F, Miyoshi H, Nose K, Shibanuma M. Transcriptional induction of MMP-10 by TGF-β, mediated by activation of MEF2A and downregulation of class IIa HDACs. Oncogene 2009; 29: 909-19.
43. Seki E, De Minicis S, Inokuchi S, et al. CCR2 promotes hepatic fibrosis in mice. Hepatology 2009; 56: 185-97.
44. Berasasin C, Castillo J, Prieto J, Avila MA. New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system. Liver Int 2007; 27: 174-85.
45. Isayama F, Hines IN, Kremer M, et al. LPS signalling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 2006; 290: G1318-28.
46. Huang WC, Sala-Newby GB, Susana A, Johnson JI, Newby AC. Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-kappa B. PLoS One 2012; 7: e42507.
47. Murray MY, Birkland TP, Howe JD, et al. Macrophage migration and invasion is regulated by MMP10 expression. PLoS One 2013; 8: e63555.
48. Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012; 143: 1158-72.
49. Chang ML, Chen JC, Alonso CR, Kornblihtt AR, Bissell DM. Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver. Proc Natl Acad Sci USA 2004; 101: 18093-8.
50. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates toll-like receptor 4. J Biol Chem 2001; 276: 10229-33.
51. Treiber M, Neuhöfer P, Anetsberger E, et al. Myeloid, but not pancreatic, RelA/p65 is requiered for fibrosis in a mouse model of chronic pancreatitis. Gastroenterology 2011; 141: 1473-85.
52. Strey CW, Markiewski M, Mastellos D, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 2003; 198: 913-23.
53. Mitchell C, Willenbring H. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protocols 2008; 3: 1167-70.
54. Fickert P, Trauner M, Fuchsbichler A, et al. Oncosis represents the main type of cell death in mouse models of cholestasis. J Hepatol 2005; 42: 378-89.
55. Wagner M, Fickert P, Zollner G, et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 2003; 125: 825-38.
56. Beier JI, Luyendyk JP, Guo L, et al. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology 2009; 49: 1545-53.
57. Weeerasinghe SVW, Moons D, Altshuler PJ, Shah YM, Omary MB. Fibrinogen-γ proteolysis and solubility dynamics during apoptotic mouse liver injury: heparin prevents and treats liver damage. Hepatology 2011; 53: 1323-32.
58. Moriya K, Sakai K, Yan MH, Sakai T. Fibronectin is essential for survival but is dispensable for proliferation of hepatocytes in acute liver injury in mice. Hepatology 2012; 56: 311-21.
59. Vierkotten S, Muether PS, Fauser S. Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS One 2011; 6: e22959.
60. Horowitz JC, Rogers DS, Simon RS, Sisson TH, Thannickal VJ. Plasminogen activation-induced pericellular fibronectin proteolysis promotes fibroblast apoptosis. Am J Respir Cell Mol Biol 2008; 38: 78-87.
61. Montero I, Orbe J, Varo N, et al. C-Reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells. J Am Coll Cardiol 2006; 47: 1369-78.
62. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 2008; 40: 1334-47.
63. Berasain C, Perugorria MJ, Latasa MU, et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med 2009; 234: 713-25.
64. Ruiz PA, Jarai G. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts. J Biol Chem 2011; 286: 12912-23.
65. Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2006; 316: 592-600.
66. Luyendyk JP, Mackman N, Sullivan BP. Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury. Toxicol Sci 2011; 119: 233-43.
67. Anstee QM, Goldin RD, Wright M, et al. Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies. J Thromb Haemost 2008; 6: 1336-43.
68. Si-Tayeb K, Monvoisin A, Mazzocco C, et al. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006; 169: 1390-401.
69. Eguchi T, Kubota S, Kawata K, et al. Novel transcription factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene. Mol Cell Biol 2008; 28: 2391-413.